Enterprise Asset Management Market Sales Forecasts Reveal Positive Growth Through 2029

Future Market Insights has recently published a market research report titled “Enterprise Asset Management Market – Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029.”

Growth of Artificial Intelligence (AI) and drone-based enterprise solutions are among factors driving the enterprise asset management. AI helps improve data handling to make better decisions. Asset visibility is an important factor for implementing the EAM system. Asset visibility gives accurate information on the identities, materials, and supplies.

Effective asset management helps control or eliminate overstocking and stockpiling, as well as helps reduce fixed capital investments. EAM software offers more robust analytical systems for managing assets, preventative maintenance, and workflow analysis. 

The growing deployment of IoT in smartphones and laptops is increasing the usage of IoT-based applications. The integration of IoT with EAM provides the identification of performance and control modifications. IoT applications allow better asset utilisation tracking and better data management, as well as streamline data in a manner in which asset lifecycle and maintenance can be analysed. Integrating EAM systems and IoT enable companies to identify problems with their assets.

The integration of IoT with EAM solutions is expected to play an important role in the development of smart cities. Smart cities monitor the conditions of the all the critical infrastructure.

Due to the increasing demand for ensuring asset performance and advanced environmental sustainability, companies are focusing on asset-intensive platforms to constantly track, assess, and manage reliability and technological & human assets. For the use of asset-intensive systems to offer efficient data management and better asset utilisation, the global enterprise asset management market is likely to record an approximate incremental opportunity of US$ 5,500 Mn during the forecast period of 2019 to 2029. In the global enterprise asset management report, FMI has segregated the global enterprise asset management market by deployment, by component, by industry verticals, and by region. With regards to component, the global enterprise asset management market is segmented into software and services. Due to the positive outlook towards the escalating demand for next-generation tracking solutions, cloud-based deployment is estimated to generate potential growth opportunities for the enterprise asset management software providers. Furthermore, the software sub-segment is also expected to witness a high CAGR during the forecast period. This growth can be attributed to the wide adoption of these devices in IoT applications to reduce errors.

With regards to deployment, the global enterprise asset management market is segmented into on-premise and cloud. Owing to the robust adoption and penetration of cloud-based systems, the cloud-based segment is expected to create potential business opportunities for the enterprise asset management market. The on-premise sub-segment is also expected to create an approximate market opportunity of US$ 4,200 Mn between 2019 and 2029. On-premise is termed as scalable, reliable, and resilient for hybrid cloud solutions. Owing to these factors, the cloud-based sub-segment will be a target area for the developers of asset maintenance applications.

Furthermore, on the basis of industry vertical, the enterprise asset management market is segmented into healthcare, manufacturing, oil & gas, banking & finance, government, and others. Spending on new & innovative advanced technologies during the adoption of cloud-based systems is expected to increase between 2019 and 2029.

In addition, with respect to geography, the enterprise asset management market in North America is projected to be a prominent player in the global enterprise asset management market owing to the advent of next-gen technological advancements in Canada and the U.S. The enterprise asset management market is estimated to generate high potential in South Asia, especially in the Chinese market. This growth potential can be attributed to the major ICT technology-based advancements in the South Asian countries. Moreover, the adoption of IoT-enabled EAM solutions is increasing in Latin America owing to free trade agreements between some countries in the region.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-193

Some of the key players included in the global enterprise asset management market report include IBM Corporation, SAP SE, Oracle Corporation, Schneider electric, ABB, and Infor.

RFID in Pharmaceuticals Market is estimated to register a Y-o-Y growth at approximately 10% in 2019

Future Market Insights has recently published a market research report titled “RFID in Pharmaceuticals Market – Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028.”

Automation in the pharmaceutical and healthcare industry has increased the efficiency of business operations and led to cost-saving, thus facilitating more accurate and reliable business operations. Across the globe, the adoption of RFID technologies has enabled pharmaceutical companies for specialized tracking and retail uses as a systemic part of the supply chain management in international pharmaceutical production and distribution, thereby driving the growth of the RFID tags market.

The pharmaceutical industry, unlike any other industry, requires a unique identification system as almost every person consumes pharmaceutical drugs. Hence, several benefits are associated with the adoption of RFID technologies in the pharmaceutical industry. The stocking of drugs and efficient supply chain management are among the major benefits offered by RFID in the pharmaceuticals industry. Furthermore, safety and security are two important features required in the pharmaceutical supply chain, and achieving the same is a challenging task. The need to secure and authenticate pharmaceutical products has increased the adoption of RFID technologies in the pharmaceutical industry.

Due to the increasing use of RFID to offer efficient expiry date management and pharmaceutical tamper detection, the global RFID in pharmaceuticals market is likely to record a total incremental opportunity of US$ 1,231.4 Mn during the forecast period of 2018 to 2028. In the global RFID in pharmaceuticals market report, Future Market Insights has segmented the global RFID in pharmaceuticals market by component, by type, by end user, by application, and by region. The component segment is further segmented into RFID readers, RFID tags, and RFID middleware. Due to the positive outlook towards the escalating demand for next-generation tracking solutions, the RFID tags sub-segment is expected to create potential growth opportunities for the providers of RFID in pharmaceuticals solutions. Furthermore, the RFID reader sub-segment is also expected to witness a high CAGR during the forecast period. This growth can be attributed to the wide adoption of these devices in pharmaceutical applications to reduce errors.

On the basis of type, the global RFID in pharmaceuticals market is sub-segmented into chipped RFID and chipless RFID. Due to the robust adoption and penetration of chipless RFID, the chipless RFID segment is expected to create potential business opportunities for the RFID in pharmaceuticals market. The chipless RFID sub-segment is also expected to create a market opportunity of US$ 950.5 Mn between 2018 and 20128. In addition, chipless RFID technology is termed as low-cost manufacturing technology because it does not require any batteries or silicon chip within the tag for asset tracking, which reduces the prices of these tags. Moreover, chipless RFID is not application-specific, due to which it can be used for various applications in the pharmaceutical industry. Due to these factors, the chipless RFID sub-segment will be a target area for the developers of RFID technology.

Furthermore, on the basis of end user, the market is sub-segmented into drug manufacturers, drug wholesalers, hospitals & clinics, and others. Due to the increasing spending of drug wholesalers on advanced supply chain systems, the drug wholesalers sub-segment is expected to be the target area for the providers of RFID in pharmaceuticals.

Based on application, the RFID in pharmaceuticals market is sub-segmented into drug tracing system, drug quality management, and others. Due to the increasing demand for the efficient supply chain of drugs, the drug tracking sub-segment is expected to grow with a high CAGR during the forecast period.

In addition, on the basis of geography, North America is expected to dominate in the global RFID in pharmaceuticals market due to the advent of next-generation technological advancements in the U.S. and Canada. The RFID in pharmaceuticals market has high potential in India and China owing to major technological advancements in these countries. Moreover, the adoption of RFID technology is increasing in Latin America owing to free trade agreements between some countries in the region.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-9508

Some of the key players in the global RFID in pharmaceuticals market research report include Alien Technology, Thinfilm Electronics, IBM Corporation, Turck Korea, CCL Label, Zebra Technologies, Texas Instruments, and Xerox Corporation.

Perimeter Intrusion Detection Market is likely to record a total incremental opportunity of US$ 25,679.2 Mn by 2028

Future Market Insights has recently published a market research report titled “Perimeter Intrusion Detection Market – Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028.”

Nowadays, for several industrial verticals, perimeter intrusion detection system are at the centre of their focus for establishing a security plan. Industry vertical across the globe are adopting advanced security and surveillance systems to increase their internal and external security. Moreover, governments across the globe are increasing the security at their borders for protection against terrorist attacks. These are some of the prominent factors that are boosting the global perimeter intrusion detection market.

The global perimeter intrusion detection market is likely to record a total incremental opportunity of US$ 25,679.2 Mn during the forecast period of 2018 to 2028. In the global perimeter intrusion detection market report, Future Market Insights has segmented the global perimeter intrusion detection market by component, by type, by vertical, and by region. The component segment is further segmented into solution and services. Due to rapid adoption of next-generation and cloud-based solutions, the solution sub-segment is expected to create potential growth opportunities for the providers of perimeter intrusion detection solutions.

On the basis of type, the global perimeter intrusion detection market is sub-segmented into barrier-mounted, ground-based, free-standing, and rapidly deployable. Due to the rising integration of advanced sensors with barrier-mounted perimeter intrusion detection systems, the market is expected to witness an incremental opportunity of US$ 7,494.6 Mn between 2018 and 2028. On the other hand, the ground-based perimeter intrusion detection system sub-segment is expected to exhibit a CAGR of 14.3% during the forecast period.

Based on vertical, the perimeter intrusion detection system market is sub-segmented into military & defence, government, industrial, critical infrastructure, commercial, residential, and others. Due to increasing demand from the commercial sector, the commercial sub-segment is expected to create potential growth opportunities for the providers of perimeter intrusion detection systems. Furthermore, with the rising adoption of advanced security systems in the industrial sector, the industrial sub-segment is expected to grow with a high CAGR during the forecast period.

In addition, on the basis of geography, North America is expected to dominate in the global perimeter intrusion detection market due to the advent of next-generation technological advancements in the U.S. and Canada. The perimeter intrusion detection market has high potential in China owing to major technological advancements in the country. China is now the most connected country in the world. In the recent years, the perimeter intrusion detection market in China has witnessed a significant growth. The Europe perimeter intrusion detection market will be a target market for market participants because governments in the region are promoting and supporting advanced security systems. Latin America is estimated to grow with a high CAGR over the forecast period.

Furthermore, the vital need for security against terrorist activities and the rising government budget for the defence sectors are among factors that have revolutionised the security infrastructure of various developed and developing regions. To keep up with the growing demand from the Asia Pacific and MEA regions, several security infrastructure component providers have started investing heavily in these regions.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-3064

Some of the key players in the global perimeter intrusion detection market research report include Honeywell International Inc., Johnson Controls Inc., Anixter, Schneider Electric SE, Axis Communications, Flir Systems, Rbtec Perimeter Security Systems, and Singapore Technologies Engineering Ltd. These perimeter intrusion detection providers are continuously focusing on offering advanced products and following the strategy of entering into partnerships and collaborations with other perimeter intrusion detection system providers to offer advanced perimeter intrusion detection systems and to reach new growth markets in the next few years.

Growth in the Elderly Population that is Susceptible to Fractures and Delayed Bone Healing is expected to boost the Bone growth stimulators Market

Osteoporosis and osteoarthritis are among the common disabling joint disorders that are affecting millions of elderly people across the world. Some of the most common sites of osteoporotic fractures are the spine, wrists, hips, and shoulders. Thus, the increasing population suffering from orthopaedic disease is creating high demand for bone growth stimulators. The cause of delayed bone healing and fractures is not known, however, it is creating a large economic impact on the market of bone growth stimulators.

Various alternative therapies and treatments for fractures, which include synthetic bone grafts, amputation, and allografts, as well as non-invasive therapies, such as electrical bone growth stimulation and low-intensity ultrasound stimulations, have been introduced, which are responsible for driving the global bone growth stimulators market. According to the latest research by FMI, the global Bone growth stimulators market is expected to account for US$ 1,387.7 Mn by the end of 2029. The Bone growth stimulators market is estimated to grow at a CAGR of 5.2% through the forecast period 2019-2029. However, factors such as the high prices of devices and product recalls are expected to hamper the growth of the bone growth stimulators market.

Over the past decades, spending on healthcare has grown globally. The growth of the emerging markets and increasing geriatric population in developed economies are among factors expected to boost healthcare spending, which is expected to subsequently expand the Bone growth stimulators market. Increasing healthcare spending is expected to boost the demand for bone growth stimulators, which is, in turn, predicted to create high growth opportunities for players in the Bone growth stimulators market over the forecast period.

Furthermore, the increasing number of fractures and technological advancements have increased non-invasive, and rapid technologies in the healthcare industry, which is boosting the bone growth stimulators market. Moreover, manufacturers are undertaking various efforts to provide bone growth stimulators that are more versatile and more convenient for patient use. According to the World Bank, around 1.25 million people get injured in road accidents, which leads to fractures and the requirement of fusion surgeries for their treatment every year. These are some of the prime factors that are expected to drive the global Bone growth stimulators market over the forecast period 2019-2029.

The North America Bone growth stimulators market and Europe Bone growth stimulators market combined are expected to hold a share of approximately 65% of the global Bone growth stimulators market during the forecast period. This can be mainly attributed to the high adoption of advanced technology and reduced hospital visits.

Some of the key players operating in the Bone growth stimulators market are Zimmer Biomet Holdings Inc., Bioventus LLC, DJO Global, Orthofix Holdings, Inc., Ossatec Benelux Ltd., IGEA, and Ito Co., Ltd.

The global Bone growth stimulators market has been studied based on the product type, application, end user, and region. Based on the product type, the global Bone growth stimulators market has been segmented broadly into non-invasive bone Growth Stimulators and Invasive bone growth stimulators. Non-invasive bone growth stimulators are also segmented into various other sub-segments such as Capacitive Coupling (CC) devices, Pulsed Electromagnetic Field (PEMF) devices, Combined Magnetic Field (CMF) devices, and ultrasound bone growth stimulators. The non-invasive bone growth stimulators segment is expected to hold a prominent share of the global Bone growth stimulators market.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-828

Based on applications, the Bone growth stimulators market has been segmented into trauma injury & fractures, spinal fusion surgeries, and osteogenesis. In terms of revenue, the trauma injury and fractures segment dominated the global Bone growth stimulators market in 2018. Based on the end user, the Bone growth stimulators market is segmented into hospitals, homecare settings, orthopaedic clinics, and ambulatory surgical centres. The hospitals segment held the maximum share of the Bone growth stimulators market in 2018, and is predicted to continue to dominate the market throughout the forecast period.

Sequencing Kits and Reagents Segment is expected to Exhibit a High Revenue Share in the Clinical Oncology Next-Generation Sequencing Market during 2019-2029

Next-generation sequencing refers to the identification of the nucleotides of DNA base pairs for the diagnosis of various diseases. Oncology is one of the important applications of next-generation sequencing. It is an advanced and faster method of sequencing.

Clinical oncology next-generation sequencing includes kits & reagents, services, sequencing platforms, and sequencing products. The kits and reagents used for sequencing are expected to witness significant growth in the overall market.

Based on the technology, the clinical oncology next-generation sequencing market has been segmented into pyro sequencing, pyro-sequencing, Sequencing by Synthesis (SBS), and Single-Molecule Real-Time Sequencing (SMRT), nanopore sequencing, ligation sequencing, and reversible dye termination sequencing. Synthesis sequencing is expected to hold a significant share in the clinical oncology next-generation sequencing market.

Ion semiconductor sequencing is a method of DNA sequencing in which hydrogen ions are detected based on the polymerisation of DNA. Pyro-sequencing includes identifying the order of nucleotides in DNA based on the “sequencing by synthesis” principle, in which the sequencing is performed with the help of DNA polymerase. SBS is a technique used to determine the series of base pairs in DNA, which is also known as DNA sequencing.

There are various applications associated with clinical oncology next-generation treatment market. They include whole tumor genome sequencing, whole tumour exome sequencing, targeted tumour genome profiling, tumour transcriptome sequencing, tumour-normal comparisons, and other applications. Targeted tumor genome profiling is expected to hold a large share of the clinical oncology next-generation treatment market.

On the basis of end user, the clinical oncology next-generation sequencing market has been segmented into hospital laboratories, clinical research organisations, diagnostic laboratories, and others. Clinical research laboratories are expected to hold a large revenue share in the clinical oncology next-generation sequencing market.

Apart from the factors driving the clinical oncology next-generation sequencing market, there are few factors that are likely to hinder the overall growth of the clinical oncology next-generation sequencing market.

There are various factors affecting the growth of the clinical oncology next-generation sequencing market.  

However, some of the factors hampering the growth of the clinical oncology next-generation sequencing market include the high cost associated with the establishment of sequencing platforms, low quality of outsourcing services, and lack of availability of sequencing platforms in some regions, among others.

On the other hand, increasing biomedical research using clinical oncology, increasing government funding for life science projects, substantial decline in the prices of sequencing, technological advancements in the field of sequencing, etc., are some of the major factors driving the growth of the clinical oncology next-generation sequencing market.

North America is expected to be a prominent region in the global clinical oncology next-generation sequencing market because of the presence of well-developed healthcare infrastructure and numerous technological advancements in the region. North America and Europe are expected to witness a significant growth rate in the clinical oncology next-generation sequencing market.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-9543

The report tracks some of the key companies operating in the clinical oncology next-generation sequencing market such as QIAGEN N.V., Thermo Fisher Scientific., Pacific Biosciences of California, Inc., F. Hoffmann-La Roche Ltd Oxford Nanopore Technologies, Ltd., Takara Bio, Inc., , Illumina Inc., PerkinElmer Inc.and Agilent Technologies, Inc.

Thermo Fischer Scientific, Oxford Nanopore Technologies Ltd., and Illumina are expected to hold a signficant share of the clinical oncology next-generation sequencing market. These first tier companies hold a share of approximately 60% in the clinical oncology next-generation sequencing market.

Frequency Counter Market is estimated to surpass US$ 2,500 Mn in 2019

Frequency Counter Sales Soar as Demand for High Resolution Measuring Devices Gain Grounds

As per the latest report published by Future Market Insights (FMI), worldwide sales of frequency counter is estimated to surpass US$ 2,500 Mn in 2019. Market gains are upheld by the ever-increasing demand for frequency counters from multiple end use industries, such as telecommunication, defence, aerospace, and automotive. In addition, need for precise measurement of various communication parameters, including time interval, period, pulse, and calibration of wireless devices, is further likely to sustain high demand for frequency counters in 2019 and beyond.

Rising need to track essential parameters and associated technical requirements is among the key factors bolstering adoption of frequency counters in wireless & communication technologies space. Sensing diverse requirements of varying end use applications, manufacturers are commercializing frequency counters of different types best-suited to the target application, including handheld and benchtop frequency counters. Frequency counter assists in impeccable measurement of intervals amidst production cycles, which is another crucial factor driving the frequency counters market.

Industry 4.0 to Shape Frequency Counter Market Landscape

As industry 4.0 is making inroads into the global manufacturing paradigm, operators across multiple industries are set to unlock value from it. Industry 4.0 is predominantly responsible for multiple advancements and breakthroughs making their mark in multiple industries, including communication. These advancements coupled with complex nature of operations are necessitating accurate and precise frequency counting for sound functioning, thereby favouring adoption of frequency counters, finds the report.

Manufacturers, with an objective of reaping the benefits of Industry 4.0, are preparing for futuristic disruptions that is encouraging them to experiment with new business models and deploy effective electronic equipment. According to the report, this likely to create favourable circumstances for growth of frequency counter market through 2027. Moreover, various types of frequency counters can record frequencies of different waves and wavelengths, such as sin, square, and others, which results in their comprehensive application across various industrial units.

Manufacturers Focus on Incremental Innovation & Launch of New Technologies

According to the report, manufacturers operating in the global frequency counter market are meticulously doing their bit for development of high-accuracy and precision-based frequency counters. Frequency counters based on the reciprocal counter technology are currently trending in the market, which is being considered and capitalized on by the leading market players. Moreover, manufacturers are also focusing on rolling out frequency counters with features, such as twelve-digit display, which enable the end users to detect minute changes in the frequency. In addition, key market players are engaged in developing precision devices with the adoption of advanced technologies, which is expected to enhance their foothold in the global frequency counters market.

According to the FMI analysis, the frequency counter market is characterized as a moderately-consolidated landscape. Several key players, such as Schneider Electric, Keysight Technologies, and Crompton Instruments (TE Connectivity), account for a hefty pie of the global market share. Developing and selling high-accuracy and precision-based frequency counters to customers, which are best suited as per varying industry requirements,  is among the key strategies followed by market players to increase their market share.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-8267

Some of the key manufacturers of frequency counters are OMRON Corporation, Yokogawa Electric, National Instruments, Anritsu, Fluke, ISKRA, B&K Precision Corporation, HAMEG Instruments GmbH, Berkeley Nucleonics Corp, Stanford Research Systems, Simpson Electric, and Shijiazhuang Suin Instruments Co., Ltd.

Summary- Frequency counter market is likely to witness growth at an impressive CAGR of over 7% through 2027. Benchtop frequency counter will continue to gain end user favour among all other product types. North America and Europe are poised offer revenue-making opportunities for frequency counter market players, backed by robust presence of key players and strong telecommunication infrastrcuture.

Viscosupplementation Market is expected to be valued at US$ 3,800 Mn by the end of 2028

The growth of the viscosupplementation market can be attributed to the increasing prevalence of osteoarthritis. According to the latest research by FMI, the global viscosupplementation market is expected to be valued at US$ 3,800 Mn by the end of 2028. The viscosupplementation market is expected to grow with a CAGR of 5.0% during the forecast period 2019-2029. Increase in the population suffering from osteoarthritis is creating high demand for osteoarthritis treatment and pain management drugs, which is expected to result in the robust growth of the viscosupplementation market.

Manufacturers in the viscosupplementation market follow different strategies to grow their businesses as well as to penetrate the viscosupplementation market. Viscosupplementation market players are focusing on distribution and marketing agreements to enhance their market presence. For example market players such as Anika therapeutic, Bioventus LLC, Seikagaku Corporation, and Zimmer Biomet are focusing on distribution agreements for global market expansion. For instance, DePuy Mitek, Inc. has been distributing Anika Therapeutic’s Orthovisc and Monovisc viscosupplementation products for a long period. In addition, in 2018, Seikagaku Corporation extended its distribution agreement with Bioventus LLC for the distribution of its five injections hyaluronic acid product Supartz FX in the U.S.

Manufacturers are focusing on the launch of new products in the U.S. market. Moreover, they are making efforts to receive approval for their hyaluronic acid-based products for the treatment of other types of joints, apart from the knees, in the U.S. market. Anika Therapeutics, Inc. is focusing on receiving FDA approval for its Cingal, hyaluronic acid, and corticosteroid combination injection.

Growing aging population is a major driving factor driving the viscosupplementation market. Age is an important risk factor for osteoarthritis, and epidemiological studies demonstrate a rise in the prevalence of osteoarthritis with growing age. According to CDC, the prevalence of osteoarthritis was found to be the highest in populations aged between 65 and 75 years. Viscosupplementation emerges as a prior and cost-effective treatment option to delay total knee replacement surgery, which is another major factor propelling the growth of the viscosupplementation market. Cost-analysis studies have shown that viscosupplementation delays the need to perform knee replacement by 2.6 years.

Reimbursement cutbacks are among the major factors that are expected to hamper the growth of the viscosupplementation market. American Association of Orthopedic Surgeons (AAOS) revised the long-standing clinical practice guideline for hyaluronic acid injection in May 2013, after which AAOS cannot recommend hyaluronic acid injection for patients with symptomatic knee osteoarthritis. Due to the AAOS response, most of the reimbursement payers continue deny reimbursements for hyaluronic acid injections. Moreover, the failure of clinical studies and the unavailability of FDA-approved hyaluronic acid injections for joints other than the knees are expected to restrain the growth of the viscosupplementation market.

North America is expected to dominate the global viscosupplementation market. Although developed countries dominate the market, emerging markets represent higher growth opportunities for the viscosupplementation market. For instance, China is expected to witness the highest growth rate in the viscosupplementation market over the forecast period.  Factors, such as rising healthcare facilities and disposable income, are expected to significantly boost the demand for viscosupplementation in the near future.

The global viscosupplementation market has been studied based on the product type and end user. Based on the product type, the viscosupplementation market has been segmented into three-injection viscosupplementation, single-injection viscosupplementation, and five-injection viscosupplementation. The three-injection viscosupplementation segment is expected to hold the maximum market share in the global viscosupplementation market. Based on end user, the viscosupplementation market has been segmented into hospitals, orthopedic clinics, and ambulatory surgery centers. In terms of revenue, the hospital segment of the viscosupplementation market dominated the global viscosupplementation market in 2018.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

Some of the key players operating in viscosupplementation market are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Ferring B.V., Seikagaku Corporation, Seikagaku Corporation, Chugai Pharmaceutical Co., Ltd., and Mylan N.V.

Availability of Technologically Advanced Products for Vision Screening is expected to drive the Vision Screeners Market

The rising prevalence of vision problems, advancements in technology, increasing healthcare spending, and the growing prevalence of diabetes are some of the factors responsible for driving the global vision screeners market. According to the latest research by FMI, the global vision screeners market is estimated to account for around US$ 860.0 Mn by the end of 2028. The vision screeners market is estimated to grow at a CAGR of approximately 6% over the forecast period 2019-2029. However, certain factors, such as the lack of availability of skilled professionals in developing countries and the ineffectiveness of vision screening tests, are expected to hamper the growth of the vision screeners.

Over the past few years, healthcare spending has increased across the world. The healthcare industry accounts for about 10% of the global GDP. Growing affluence in the developing markets and rapidly increasing aging population are expected to boost healthcare spending, which is expected to subsequently boost the vision screeners market. Increasing healthcare spending is expected to boost the demand for the treatment for vision disorders, which is, in turn, expected to create high growth opportunities for players in the vision screeners market over the forecast period.

Furthermore, the rising elderly population that is susceptible to vision problems is expected to fuel the growth of the global vision screeners market. Age brings changes that usually weaken the vision and eyes, thus, the elderly population has a higher risk of developing age-related eye diseases and conditions such as cataract, age-related macular degeneration, diabetic eye disease, low vision, glaucoma, and dry eyes. Age-related Macular Degeneration (AMD) is considered to be a leading cause of loss of vision in people aged over 65 years. There are several eye diseases that lack early warning symptoms, which can be screened using vision screeners before vision loss occurs.

It has been observed that the prevalence of eye diseases is majorly increasing among young children. The excess usage of computer and mobile phones is responsible for the increased chance of eye disorders. Such poor lifestyle habits lead to digital eye strain, which is also known as computer vision syndrome. Across all the age groups in developed regions, engagement with digital devices has drastically increased in the recent years, especially in the field of mobile media. According to a European study, it was reported that around 68% of children regularly use a computer and 54% engage in online activities. The increasing prevalence of eye diseases among young children is boosting the adoption of vision screeners, which is consequently boosting the vision screeners market.

Moreover, the market for vision screeners is growing due to the increasing availability of technologically advanced vision screeners. Advancements in the field of technology have enabled the early diagnosis of eye diseases with the help of vision screeners. There are digital vision screeners and computer-based vision screeners. New and advanced technologies are enabling the diagnosis of various eye diseases among all age groups. This is boosting the demand for vision screeners in the developing and emerging regions, thus fuelling the growth of the vision screeners market worldwide. These are some of the prime factors that are expected to contribute to the growth of the global vision screeners market over the forecast period 2019-2029.

However, lack of skilled professionals is likely to restrain the growth of the global vision screeners market. Untrained individuals do not have the knowledge to competently assess screening results. Emerging countries of the Asia Pacific region do not have the required number of skilled professionals for patient handling and care. Furthermore, vision screening tests cannot be performed on children who have reading problems such as hyperopia or astigmatism. Hence, the ineffectiveness of vision screeners is expected to decrease the number of parents opting for vision screening tests for their children.

The North America vision screeners market and Europe vision screeners market are expected to contribute a combined share of over 60% of the global vision screeners market during the forecast period. This can be primarily attributed to the high adoption of advanced technology and the consolidation of healthcare facilities.

Some of the key players of the vision screeners market are Hill-Rom Holdings, Inc. (Welch Allyn), Essilor International S.A. (Stereo Optical Company Inc.), Adaptica S.r.l., OCULUS Surgical, Inc., Plusoptix Inc., Honeywell International Inc., FIM Medical SAS, SHANGHAI TOP VIEW INDUSTRIAL CO., LTD., Thomson Screening Solutions Ltd., and Keystone View.

Request For report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-5032

The global vision screeners market has been studied based on the product type, technology, application, end user, and region. Based on the product type, the global vision screeners market has been segmented broadly into table-top vision screeners, portable/handheld vision screeners, and vision screening software. Based on technology, the vision screeners market has been segmented into digital vision screeners and computer-based vision screeners. In terms of revenue, the digital vision screeners segment dominated the global vision screeners market in 2018. Based on the application, the global vision screeners market has been segmented into vision screening tests, color vision tests, binocular testing, and others. Based on the end user, vision screeners market is segmented into hospital outpatient, physician practice (primary care physicians), specialty clinics, ambulatory surgical centers, and educational institutes/schools.

Venous Thromboembolism Treatment Market revenues will observe approximately 4% CAGR between 2019 and 2029

Venous thromboembolism treatment includes segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, lower pneumatic compression sleeves, non-segmented pneumatic compression pumps permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, Catheter-Directed Thrombolysis (CDT) devices and upper pneumatic compression sleeves.

Based on the disease indication, the venous thromboembolism treatment market has been segmented into deep venous thrombosis and pulmonary embolism. Deep vein thrombosis is expected to hold a prominent share in the overall venous thromboembolism treatment market.

Several factors are impacting the overall growth of the venous thromboembolism treatment market. The first and the most important factor driving the venous thromboembolism treatment market is the increasing prevalence of venous thromboembolism disease. Other factors, such as the increasing retrieval rate of vena cava filters, increasing healthcare awareness, presence of favourable reimbursement policies, and increasing geriatric population, are also responsible for the growth of the venous thromboembolism treatment market.

The increasing number of hospitals and diagnostic centres is expected to boost the venous thromboembolism treatment market. Increasing number of surgical procedures is another factor that is likely to contribute to the growth of the venous thromboembolism treatment market.

Apart from the driving factors of venous thromboembolism treatment market, there are few factors that are likely to hinder the overall growth of the venous thromboembolism treatment market. The high cost associated with venous thromboembolism treatment therapy, poor reimbursement for some of the treatment devices, and poor insurance support are among the major factors that are expected to hamper the growth of the venous thromboembolism treatment market.

The increasing preference for drug-based venous thromboembolism treatment is also likely to hinder the growth of the market. New-generation drugs, which include Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) such as dabigatran, rivaroxaban, apixaban, and edoxaban, are estimated to boost the adoption rate of venous thromboembolism treatment due to increased efficacy.

However, there are regional variations to this trend. Treatment using mechanical and interventional prophylaxis systems is expected to be increasingly adopted in the North American region during the forecast period. In addition, drug-based treatment is expected to gain popularity in the European region, which is expected to subsequently decrease the usage of mechanical and interventional treatments in the region.

On the other hand, increasing per capita healthcare expenditure is one of the macroeconomic factors that is likely to boost the market. Nowadays, certain changes in the socio and economic scenario can also lead to significant growth in the venous thromboembolism treatment market.

Some of the key manufacturers of venous thromboembolism treatment are mainly focusing on innovating and launching new and advanced products. Major players in the venous thromboembolism treatment market are focusing on collaborations and acquisitions. For example, Venous Thromboembolism Treatment is majorly adopted by hospitals, catheterisation laboratories, and ambulatory surgical centres. Hospitals are expected to hold a significant revenue share in the venous thromboembolism treatment market.

North America is expected to be a prominent region in the global venous thromboembolism treatment market because of the presence of a well-developed healthcare infrastructure and numerous technological advancements in the region. The increasing prevalence of venous thromboembolism is also responsible for the boosting the growth of the North America market.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1341

The report tracks some of the key companies operating in the Venous Thromboembolism Treatment market such as ArjoHuntleigh AB, AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc., Boston Scientific Corp.  There are several other companies operating in the venous thromboembolism treatment market.

AngioDynamics, Boston Scientific Corp., and Cardinal Health Inc. are expected to hold a prominent share of the Venous Thromboembolism Treatment market. These tier 1 companies hold a share of approximately 35% in the venous thromboembolism treatment market.

Global Automotive Display Units Market is Estimated to Witness a CAGR of around 8.0% During 2019 – 2029

Future Market Insights has published a recent report on the automotive display units market. The report, titled, ‘Automotive Display Units Market: Global Industry Analysis 2014–2018 and Opportunity Assessment 2019–2029”, covers the latest trends, key success factors, key information, market influencing factors, and macroeconomics factors, along with the historical market scenario. FMI has conducted a deep-dive research on the automotive display units market. The automotive display units market report estimates that the full digital and navigation display segments are expected to create significant growth opportunities in the global automotive display units market, in terms of both, volume and value, during the forecast period. The value of the global automotive display units market was approximately US$ 12 Mn in 2018. The automotive display units market is predicted to grow at a prominent CAGR of around 8.0% during the forecast period.

Global Automotive Display Units Market Dynamics: Head-Up Display an Emerging Trend

In the current market scenario, technological advancements in automotive display units are estimated to become more important due to increasing penetration of navigation display systems, software, and various display technologies in automobiles. Moreover, automakers are focusing on head-up display and navigation systems in their vehicles in order to increase safety features. Automotive display manufacturers have developed technologies such as TFT LCDs and AMOLEDs, which can be used in low ambient light conditions and enhance the vehicle safety. These technologies offer various advantages such as vehicle safety, high resolution, larger display size, high heat-resistance, and lighter than a liquid crystal display (LCD) feature. Furthermore, stringent safety rules and regulations in countries such as Germany, the U.S., France, and Italy are compelling automotive manufacturers to raise the safety standards in their vehicles. To improve vehicle safety, automakers are trying to implement digital rear view mirrors and a pillar mirror to reduce the blind spots for vehicles, which is expected to support the demand for TFT, LCD, and AMOLED displays in the automotive display units market.

The growing sales of premium LCVs and HCVs in developed and developing economies are estimated to boost the growth of the automotive display units market. China is expected to be a prominent market in the global automotive display units market over the forecast period in term of volume, owing to the increasing demand for passenger cars from the middle-class population. Moreover, government initiatives to promote the manufacturing sector in developing countries such as India are expected to further create opportunities in the automotive display units market. These factors are expected to directly impact the growth of the automotive display units market during the assessment period.

Global Automotive Display Units Market Forecast: China and India are Expected to Create Significant Growth Opportunities During the Assessment Period

This global automotive display units market report observes that, East Asia is estimated to hold a prominent share in the global automotive display units market during the assessment period. Due to increasing vehicle production and rising vehicle safety standards, the demand for automotive display units is increasing across the globe. China is estimated to hold a significant share in the East Asia Automotive Display Units market, and drive the growth of the region, while growing at a CAGR of nearly 10% in terms of value, between 2019 and 2029. This automotive display units market report studies the concerned markets across various regions, including North America, Latin America, Europe, East Asia, South Asia, and the Middle East & Africa. We have also considered all prominent macroeconomic and forecast factors while calculating the automotive display units market size. By product type, full digital and navigation display systems are expected to play a vital role in generating market revenue in the automotive display units market.

Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-9539

Global Automotive Display Units Market: Competitive Landscape

Some of the key players involved in the manufacturing of automotive display units, and included in this study are Robert Bosch GmbH, LG Displays, Panasonic Corporation, Denso Corporation, Magna International Inc., Valeo Sa, Delphi Automotive Plc, Continental Ag, Kyocera Corporation, Japan Display Inc., Au Optronics, and Pioneer Corporation, amongst others.